The DRAIHA study: Data Registry of AutoImmune Hemolytic Anemia, to improve diagnostic testing for the development of personalized treatment protocols in AIHA patients
Recruiting
- Conditions
- antibody mediated destruction of red bloodcellsauto-immune hemolytic anemia1001891110003816
- Registration Number
- NL-OMON54572
- Lead Sponsor
- Sanquin Bloedbank
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 155
Inclusion Criteria
Patients with a positive DAT, a positive eluate and signs of hemolysis
Patients with a positive DAT with complement only, negative eluate and sings of
hemolysis
Blood donors with a positive direct antiglobulin test and a positive eluate
and/or clinically relevant cold auto-antibodies.
Exclusion Criteria
No informed consent
Insufficient comprehension of the Dutch language
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method